Bio-Rad Laboratories, Inc. (BIO)
384.15
+3.19
(+0.84%)
USD |
NYSE |
Sep 02, 13:15
Bio-Rad Laboratories Research and Development Expense (TTM) : 260.70M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 260.70M |
| March 31, 2026 | 260.30M |
| December 31, 2025 | 257.60M |
| September 30, 2025 | 259.40M |
| June 30, 2025 | 249.90M |
| March 31, 2025 | 248.40M |
| December 31, 2024 | 252.18M |
| September 30, 2024 | 246.59M |
| June 30, 2024 | 214.23M |
| March 31, 2024 | 218.86M |
| December 31, 2023 | 225.64M |
| September 30, 2023 | 229.83M |
| June 30, 2023 | 267.90M |
| March 31, 2023 | 268.30M |
| December 31, 2022 | 257.09M |
| September 30, 2022 | 259.61M |
| June 30, 2022 | 257.08M |
| March 31, 2022 | 258.02M |
| December 31, 2021 | 255.40M |
| September 30, 2021 | 252.25M |
| June 30, 2021 | 247.51M |
| March 31, 2021 | 234.21M |
| December 31, 2020 | 226.20M |
| September 30, 2020 | 211.40M |
| June 30, 2020 | 199.90M |
| Date | Value |
|---|---|
| March 31, 2020 | 197.94M |
| December 31, 2019 | 196.61M |
| September 30, 2019 | 198.72M |
| June 30, 2019 | 200.42M |
| March 31, 2019 | 198.14M |
| December 31, 2018 | 200.00M |
| September 30, 2018 | 222.96M |
| June 30, 2018 | 235.30M |
| March 31, 2018 | 250.13M |
| December 31, 2017 | 250.16M |
| September 30, 2017 | 231.66M |
| June 30, 2017 | 219.51M |
| March 31, 2017 | 206.69M |
| December 31, 2016 | 205.82M |
| September 30, 2016 | 204.17M |
| June 30, 2016 | 197.58M |
| March 31, 2016 | 194.36M |
| December 31, 2015 | 192.97M |
| September 30, 2015 | 196.37M |
| June 30, 2015 | 205.82M |
| March 31, 2015 | 214.99M |
| December 31, 2014 | 220.33M |
| September 30, 2014 | 216.89M |
| June 30, 2014 | 217.03M |
| March 31, 2014 | 214.54M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Thermo Fisher Scientific, Inc. | 1.403B |
| Agilent Technologies, Inc. | 480.00M |
| Danaher Corp. | 1.615B |
| Illumina, Inc. | 963.00M |
| Revvity, Inc. | 215.83M |